No Data
No Data
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Quantum Corporation (NASDAQ:QMCO) fell sharply during Tuesday's session after the company reported worse-than-expected FY24 financial results and issued FY25 guidance below estimates.Quantum
Cantor Fitzgerald Reiterates Overweight on Skye Bioscience, Maintains $14 Price Target
Cantor Fitzgerald analyst Kristen Kluska reiterates Skye Bioscience (NASDAQ:SKYE) with a Overweight and maintains $14 price target.
Skye Bioscience Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/17/2024 33.59% Cantor Fitzgerald $14 → $14 Reiterates Overweight → Overweight 05/23/2024 100.38% Cantor
Express News | Skye Bioscience Inc : Oppenheimer Cuts Target Price to $21 From $25
Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Skye Bioscience, Inc. (NASDAQ:SKYE) fell sharply during Monday's session after the company announced its SBI-100 Ophthalmic Emulsion Phase 2a trial did not achieve target product profile and
Skye Bioscience Pulls Plug on Glaucoma Drug, Stock Tumbles 15%
Skinny bulldogOP : Look at the other company in the same industry you will know. The problem is, how high it can go.